Kauppila A, Kuikka J, Tuimala R
Obstet Gynecol. 1978 Nov;52(5):558-62.
The use of beta-adrenergic agonists in high-risk pregnancies has shown evidence of favorable effects on the fetus. Intravenous injections of 133Xe were given to evaluate the effects of short-term administration of fenoterol (3 microgram/min) and isoxsuprine (150 migrogram/min) on the intervillous and myometrial blood flow in a series of 48 women during the last trimester of pregnancy. Both fenoterol and isoxsuprine treatment increased the maternal heart rate significantly. There was a significant rise in myometrial blood flow when fenoterol was given, but the intervillous blood flow did not change significantly during the administration of either isoxsuprine or fenoterol. Previous oral isoxsuprine treatment did not diminish the cardiac effect of intravenous fenoterol, but the improvement in myometrial blood flow was eliminated. This result indicates that beta-adrenergic agonists may have a specific dilatational effect on the myometrial blood vessels. From the hemodynamic point of view, the beta-adrenergic agonists have a limited value in the treatment of chronic fetal asphyxia or intrauterine fetal growth retardation.
在高危妊娠中使用β-肾上腺素能激动剂已显示出对胎儿有有利影响的证据。对48名处于妊娠晚期的妇女静脉注射133Xe,以评估短期给予非诺特罗(3微克/分钟)和异克舒令(150微克/分钟)对绒毛间隙和子宫肌层血流的影响。非诺特罗和异克舒令治疗均显著提高了母体心率。给予非诺特罗时子宫肌层血流显著增加,但在给予异克舒令或非诺特罗期间绒毛间隙血流无显著变化。先前口服异克舒令治疗并未减弱静脉注射非诺特罗的心脏效应,但子宫肌层血流的改善消失了。这一结果表明,β-肾上腺素能激动剂可能对子宫肌层血管有特定的扩张作用。从血流动力学角度来看,β-肾上腺素能激动剂在治疗慢性胎儿窒息或胎儿宫内生长受限方面价值有限。